FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

377356001: Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2639000014 Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2642979011 Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4218611000005117 difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml Is a difterivaccine false Inferred relationship Some
    difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml Is a tetanusvaccine false Inferred relationship Some
    difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml Is a Haemophilus influenzae type b-vaccine false Inferred relationship Some
    difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanustoxoid false Inferred relationship Some
    difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccine mod influenzavirus false Inferred relationship Some
    difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. difterivaccine false Inferred relationship Some
    difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccine mod Haemophilus influenzae type B false Inferred relationship Some
    difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml Is a difteri- + tetanus- + Haemophilus influenzae type b-vaccine false Inferred relationship Some
    difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml Has manufactured dose form injektionsvæske false Inferred relationship Some
    difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Diphtheria vaccine false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start